About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted,” said Sheila Irvine, ...

CINCINNATI—Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver ...

Every year, the MIT Technology Review newsroom produces this list of some of the most promising climate tech firms on the planet. It’s an exercise that we hope brings positive attention to companies ...

Once again, AI dominates the agenda when it comes to discussing the most significant and impactful trends of the coming year. But with 2026 fast approaching, the conversation isn’t just around what AI ...

WASHINGTON - APRIL 11: Department Of Health and Human Services, Hubert H. Humphrey Building on April 11, 2015 in Washington, D.C. (Photo By Raymond Boyd/Getty Images) The Department of Health and ...

An innovative Minnesota company broke ground Friday on its planned manufacturing facility, allowing it to soon scale up its cutting-edge technology that is essential to power consumer products from ...